WO2003070017A3 - Novel soy protein products - Google Patents

Novel soy protein products Download PDF

Info

Publication number
WO2003070017A3
WO2003070017A3 PCT/IB2003/000676 IB0300676W WO03070017A3 WO 2003070017 A3 WO2003070017 A3 WO 2003070017A3 IB 0300676 W IB0300676 W IB 0300676W WO 03070017 A3 WO03070017 A3 WO 03070017A3
Authority
WO
WIPO (PCT)
Prior art keywords
soy protein
protein products
preventing
treating
present
Prior art date
Application number
PCT/IB2003/000676
Other languages
French (fr)
Other versions
WO2003070017A2 (en
Inventor
Lars Henrik Hoeie
Karl Johan Naadland
Original Assignee
Nutri Pharma Danmakr Holding A
Lars Henrik Hoeie
Karl Johan Naadland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Pharma Danmakr Holding A, Lars Henrik Hoeie, Karl Johan Naadland filed Critical Nutri Pharma Danmakr Holding A
Priority to EP03702932A priority Critical patent/EP1480525A2/en
Priority to AU2003206049A priority patent/AU2003206049A1/en
Publication of WO2003070017A2 publication Critical patent/WO2003070017A2/en
Publication of WO2003070017A3 publication Critical patent/WO2003070017A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention concerns novel soy protein products containing soy protein in a form which result in maximum cholesterol-lowering ingested and also concerns methods for manufacturing said soy protein preparations. Furthermore, the present invention relates to soy protein products suitable for preventing, treating and/or alleviating cardiovascular diseases such as hypercholesterolemia, hypertriglyceridemia, hyperlipidemia, arterisclerosis, hypertension and related cardiovascular diseases, for preventing and/or treating type 2 diabetes and/or the metablic syndrome, and for preventing, treating and/or alleviating pulmonary diseases. The present invention also pertains to the use of such soy protein products in the prevention and/or treatment of a cardiovascular disease in a subject suffering from type 2 diabetes.
PCT/IB2003/000676 2002-02-23 2003-02-24 Novel soy protein products WO2003070017A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03702932A EP1480525A2 (en) 2002-02-23 2003-02-24 Novel soy protein products
AU2003206049A AU2003206049A1 (en) 2002-02-23 2003-02-24 Novel soy protein products

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02004044 2002-02-23
EP02004044.0 2002-02-23

Publications (2)

Publication Number Publication Date
WO2003070017A2 WO2003070017A2 (en) 2003-08-28
WO2003070017A3 true WO2003070017A3 (en) 2003-12-31

Family

ID=27741111

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/000676 WO2003070017A2 (en) 2002-02-23 2003-02-24 Novel soy protein products

Country Status (3)

Country Link
EP (1) EP1480525A2 (en)
AU (1) AU2003206049A1 (en)
WO (1) WO2003070017A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150196045A1 (en) * 2012-07-10 2015-07-16 Burcon Nutrascience (Mb) Corp. Ph adjusted pulse protein product
CN113068840A (en) * 2021-04-25 2021-07-06 华南理工大学 Protein with cholesterol lowering effect and preparation method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377392A (en) * 1971-03-25 1974-12-18 Unilever Ltd 'oy protein compositions
US4307014A (en) * 1980-09-22 1981-12-22 General Foods Inc. Soybean protein isolate production
US6005076A (en) * 1996-01-31 1999-12-21 B.M.W.Canola Inc. Oil seed protein extraction
WO2000019839A2 (en) * 1998-10-07 2000-04-13 Monsanto Company High-beta-conglycinin products and their use
WO2000030663A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
WO2000030665A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
WO2000030664A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
WO2000062623A1 (en) * 1999-04-16 2000-10-26 Fuji Oil Company, Limited Process for producing soybean protein

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377392A (en) * 1971-03-25 1974-12-18 Unilever Ltd 'oy protein compositions
US4307014A (en) * 1980-09-22 1981-12-22 General Foods Inc. Soybean protein isolate production
US6005076A (en) * 1996-01-31 1999-12-21 B.M.W.Canola Inc. Oil seed protein extraction
WO2000019839A2 (en) * 1998-10-07 2000-04-13 Monsanto Company High-beta-conglycinin products and their use
WO2000030663A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
WO2000030665A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
WO2000030664A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
WO2000062623A1 (en) * 1999-04-16 2000-10-26 Fuji Oil Company, Limited Process for producing soybean protein

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANDERSON J W ET AL: "META-ANALYSIS OF THE EFFECTS OF SOY PROTEIN INTAKE ON SERUM LIPIDS", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, vol. 333, 1995, pages 276 - 282, XP000878794, ISSN: 0028-4793 *
DATABASE WPI Section Ch Week 200066, Derwent World Patents Index; Class D13, AN 2000-679534, XP002243176 *
LOVATI MARIA R ET AL: "Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells.", JOURNAL OF NUTRITION, vol. 130, no. 10, October 2000 (2000-10-01), pages 2543 - 2549, XP002243172, ISSN: 0022-3166 *
SIRTORI CESARE R ET AL: "Reduction of serum cholesterol by soy proteins: Clinical experience and potential molecular mechanisms.", AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 68, no. 6 SUPPL., December 1998 (1998-12-01), Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease;Brussels, Belgium; September 19, 1996, pages 1521S, XP008017962, ISSN: 0002-9165 *
WONG WILLIAM W ET AL: "Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men.", AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 68, no. 6 SUPPL., December 1998 (1998-12-01), Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease;Brussels, Belgium; September 19, 1996, pages 1385S - 1389S, XP002243173, ISSN: 0002-9165 *

Also Published As

Publication number Publication date
EP1480525A2 (en) 2004-12-01
WO2003070017A2 (en) 2003-08-28
AU2003206049A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
WO2003004039A3 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
WO2002094228A8 (en) Prevention and treatment of allergies by helminthic regulation of ige
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
WO2002083849A3 (en) Vascular endothelial growth factor 2
IL245955A0 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2004032868A3 (en) Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
EP1352897A3 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
BG104075A (en) Combined treatment including atorvastatin and an antihypertonic form
EP2228389A3 (en) Antibodies against vascular endothelial growth factor 2
WO2002085857A3 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
WO1998051662A3 (en) Compounds and methods for the inhibition of the expression of vcam-1
WO2004043341A3 (en) Treatment for hemorrhagic shock
WO2002047668A3 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
EA200400881A1 (en) AZAARILPIPERAZINS
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
IL159960A (en) Indane acetic acid derivatives, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments
WO2001053457A3 (en) Vaccines against neurodegenerative disorders
WO2006009525A3 (en) P. aeruginosa mucoid exopolysaccharide specific binding peptides
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2003000173A3 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
WO2002017894A3 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
WO2003070017A3 (en) Novel soy protein products

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003702932

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003702932

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003702932

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP